Biomarcadores empleados en sepsis
- Ana Hernando Holgado
- Luis García de Guadiana Romualdo
- Ana Fernández Carballido
- María Dolores Albadalejo Otón
ISSN: 1697-4298, 0034-0618
Ano de publicación: 2017
Volume: 83
Número: 2
Páxinas: 175-187
Tipo: Artigo
Outras publicacións en: Anales de la Real Academia Nacional de Farmacia
Resumo
Infectious diseases, such as sepsis, are a serious health problem in the world, associated with high morbidity and mortality in all areas of health care. These are time dependent diseases in which the early application of diagnostic therapeutic actions, significantly improve patient survival and prognosis. To carry out this, we have tools such as biomarkers that help us in the diagnosis and prognosis of these pathologies; There are biomarkers widely used such as PCR, Procalcitonin or cytokines, and others that are less known as pro-adrenomedullin (pro-ADM), soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), soluble urokinase-type plasminogen activator receptor (SuPAR), Pancreatic Stone Protein (PSP) or sCD25.